risedronic acid has been researched along with Rhabdomyolysis in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimitri, D | 1 |
| Echaniz-Laguna, A | 1 |
| Mariette, X | 1 |
| Nishiguchi, T | 1 |
| Akiyoshi, T | 1 |
| Anami, S | 1 |
| Nakabayashi, T | 1 |
| Matsuyama, K | 1 |
| Matzno, S | 1 |
2 other studies available for risedronic acid and Rhabdomyolysis
| Article | Year |
|---|---|
Risedronate-induced rhabdomyolysis in a patient with inflammatory myopathy.
Topics: Humans; Muscular Diseases; Myositis; Rhabdomyolysis; Risedronic Acid | 2021 |
Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts.
Topics: Alendronate; Animals; Apoptosis; Atorvastatin; Bone Density Conservation Agents; Caspases; Cell Line | 2009 |